SCHEDULED MAINTENANCE
CuInS2 quantum dots/poly(l-glutamic acid)–drug conjugates for drug delivery and cell imaging†
Abstract
A new anticancer drug delivery system was developed based on the electrostatic complex of positively charged CuInS2 quantum dots (QDs) and negatively charged poly(L-glutamic acid) (PGA) conjugated with the model anticancer drug doxorubicin (DOX). Water-soluble near-infrared CuInS2 QDs capped with L-cysteine were directly synthesized by a hydrothermal method. DOX can quench the photoluminescence of CuInS2 QDs in QDs/PGA–DOX nanoparticles through a photoinduced electron transfer process, thus CuInS2 QDs are in the fluorescence “turn-off” state. After the QDs/PGA–DOX nanoparticles are exposed to carboxypeptidase or are taken up by cancer cells, PGA is hydrolysed to release DOX, inducing activation of the CuInS2 QDs fluorescence to the “turn-on” state. The QDs/PGA–DOX nanoparticles can deliver DOX to targeted cancer cells and monitor the DOX release based on the fluorescence “turn-on” signal of CuInS2 QDs, and this could be simultaneously used for the imaging of cancer cells. The multifunctional QDs/PGA–DOX nanoparticles have great potential in terms of their clinical application for cancer therapy.
Please wait while we load your content...
